Accuneb (Albuterol Sulfate Inhalation Solution) - Summary

ACCUNEB SUMMARY

AccuNeb^®
(albuterol sulfate)
Inhalation Solution
1.25 mgPotency expressed as albuterol, equivalent to 1.5 mg and 0.75 mg albuterol sulfate/3 mL and 0.63 mg/3 mL

AccuNeb® (albuterol sulfate) inhalation solution is a sterile, clear, colorless solution of the sulfate salt of racemic albuterol, albuterol sulfate. Albuterol sulfate is a relatively selective beta₂-adrenergic bronchodilator (see CLINICAL PHARMACOLOGY).

AccuNeb is indicated for the relief of bronchospasm in patients 2 to 12 years of age with asthma (reversible obstructive airway disease).

ACCUNEB NEWS HIGHLIGHTS

Published Studies Related to Accuneb (Albuterol Inhalation)

Early bronchodilatory effects of budesonide/formoterol pMDI compared with fluticasone/salmeterol DPI and albuterol pMDI: 2 randomized controlled trials in adults with persistent asthma previously treated with inhaled corticosteroids. [2008.05]

Comparison of nebulized epinephrine to albuterol in bronchiolitis. [2008.04]

Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]

Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]

An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]

more>>

Clinical Trials Related to Accuneb (Albuterol Inhalation)

Safety and Tolerability Study of Levalbuterol HFA and Racemic Albuterol HFA in Pediatrics Subjects With Asthma [Completed]

Study of Levalbuterol and Racemic Albuterol in Pediatric Subjects With Reactive Airways Disease (RAD) [Completed]

Controlled, 12-Week Study of Albuterol HFA Versus the Active Control, Proventil(R)-HFA in Asthmatic Patients [Active, not recruiting]

Safety and Tolerability Study of Levalbuterol HFA Compared to Racemic Albuterol HFA in Subjects With Asthma [Completed]

Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects [Completed]

more>>